Pitfalls in estimating piperaquine elimination.
By using a sensitive new assay, the terminal elimination half-life of the antimalarial piperaquine in a healthy volunteer was estimated to be 33 days, which is longer than estimated previously. This result illustrates the importance of extended sampling duration and sensitive assay methodologies in...
主要な著者: | Tarning, J, Lindegårdh, N, Annerberg, A, Singtoroj, T, Day, N, Ashton, M, White, N |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2005
|
類似資料
-
Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
著者:: Tarning, J, 等
出版事項: (2006) -
Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
著者:: Tarning, J, 等
出版事項: (2007) -
Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
著者:: Tarning, J, 等
出版事項: (2008) -
Characterization of human urinary metabolites of the antimalarial piperaquine.
著者:: Tarning, J, 等
出版事項: (2006) -
Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
著者:: Tarning, J, 等
出版事項: (2014)